|
Market Closed -
Other stock markets
|
Pre-market 14:00:22 | |||
| 496.50 USD | -0.39% |
|
491.96 | -0.92% |
| 07-09 | RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570 | MT |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.39% | -5.97% | +11.38% | +11.13% | +9.52% | +3.66% | +46.82% | +150.56% | +458.12% | 126B | |
| +0.09% | +0.25% | +6.31% | +27.40% | +13.24% | +54.65% | +169.19% | +417.87% | +1,427.68% | 1,085B | |
| -1.63% | -1.50% | +9.32% | +7.37% | +25.20% | +65.79% | +62.70% | +52.64% | +110.91% | 624B | |
| -1.12% | -4.27% | +10.86% | +17.66% | +9.37% | +31.10% | +84.44% | +114.37% | +289.51% | 442B | |
| +0.80% | -0.62% | +4.51% | +7.26% | +3.14% | +28.71% | +27.62% | -5.00% | +32.28% | 332B | |
| -1.64% | -9.05% | -2.35% | -13.67% | -4.66% | +23.73% | +29.15% | +50.05% | +188.58% | 277B | |
| +0.57% | -2.22% | +5.07% | +2.73% | +14.12% | +26.08% | +45.81% | +46.41% | +53.85% | 282B | |
| +0.45% | -1.47% | +13.78% | +33.85% | -0.97% | -29.29% | -39.33% | +18.20% | +72.85% | 217B | |
| -1.19% | -2.81% | +5.53% | +2.26% | +11.09% | +22.63% | +66.30% | +48.30% | +125.71% | 196B | |
| -0.72% | +2.72% | +7.44% | -5.10% | +9.86% | +19.07% | +81.19% | +97.65% | +55.79% | 167B | |
| +0.83% | -0.29% | -5.64% | -10.91% | -2.61% | -5.13% | -31.75% | -38.78% | -32.86% | 138B | |
| +0.70% | -0.33% | +2.58% | -2.57% | +7.42% | +21.57% | -7.52% | -13.73% | -23.03% | 118B | |
| +0.71% | -2.46% | +2.29% | -9.67% | +7.73% | +35.13% | +49.29% | +9.29% | -5.42% | 105B | |
| -0.01% | +0.87% | +0.61% | -4.64% | -7.56% | -9.14% | -18.92% | -13.89% | +2.23% | 105B | |
| +0.41% | -3.31% | -2.26% | -14.82% | -10.36% | +7.73% | +93.03% | +74.35% | +483.34% | 74.59B | |
| -1.86% | -6.82% | +40.57% | +23.93% | +34.34% | +78.98% | +0.37% | -1.87% | -46.39% | 56.94B | |
| -0.72% | 0.00% | +5.70% | -6.51% | +10.84% | +23.59% | +21.57% | +44.92% | +22.27% | 52.53B | |
| +2.96% | +3.96% | +19.90% | -2.37% | -6.65% | -2.76% | +14.92% | -10.45% | +269.59% | 54B | |
| -3.31% | +0.00% | +5.07% | -2.64% | -21.34% | -2.52% | +62.34% | +76.98% | +403.04% | 41.76B | |
| -0.03% | -0.99% | +6.68% | -0.94% | -3.77% | -3.10% | +15.82% | - | - | 42.54B | |
| Average | +0.08% | -0.91% | +7.37% | +2.99% | +4.90% | +19.52% | +38.65% | +58.84% | +204.63% | 226.82B | |
| Weighted average by Cap. | +0.15% | -1.00% | +6.69% | +10.18% | +9.62% | +33.01% | +71.47% | +136.60% | +442.93% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
